Shares of Dominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) shot up 0.3% during trading on Tuesday . The company traded as high as $2.07 and last traded at $1.96. 18,274 shares changed hands during trading, an increase of 84% from the average session volume of 9,943 shares. The stock had previously closed at $1.95.
Dominari Price Performance
The company has a market capitalization of $11.10 million, a price-to-earnings ratio of -0.40 and a beta of 0.93. The business has a fifty day moving average price of $1.73 and a 200 day moving average price of $2.09.
Dominari (NASDAQ:DOMH – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.51) earnings per share (EPS) for the quarter. The firm had revenue of $6.17 million for the quarter. Dominari had a negative net margin of 231.55% and a negative return on equity of 31.02%.
Dominari Company Profile
Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Further Reading
- Five stocks we like better than Dominari
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Leveraged ETFs to Multiply Returns
- 3 Best Fintech Stocks for a Portfolio Boost
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Dominari Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dominari and related companies with MarketBeat.com's FREE daily email newsletter.
